211 related articles for article (PubMed ID: 35446794)
21. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
22. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
[TBL] [Abstract][Full Text] [Related]
23. SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C; Le Loarer F
Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
[TBL] [Abstract][Full Text] [Related]
24. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
25. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
Chi SN; Yi JS; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey BD; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga JC; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
J Natl Cancer Inst; 2023 Nov; 115(11):1355-1363. PubMed ID: 37228094
[TBL] [Abstract][Full Text] [Related]
26. SWI/SNF chromatin remodeling complexes and cancer.
Biegel JA; Busse TM; Weissman BE
Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
[TBL] [Abstract][Full Text] [Related]
27. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
[TBL] [Abstract][Full Text] [Related]
28. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.
Frühwald MC; Nemes K; Boztug H; Cornips MCA; Evans DG; Farah R; Glentis S; Jorgensen M; Katsibardi K; Hirsch S; Jahnukainen K; Kventsel I; Kerl K; Kratz CP; Pajtler KW; Kordes U; Ridola V; Stutz E; Bourdeaut F
Fam Cancer; 2021 Oct; 20(4):305-316. PubMed ID: 33532948
[TBL] [Abstract][Full Text] [Related]
29. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
[TBL] [Abstract][Full Text] [Related]
30. [Hereditary predisposition to tumors of the central and peripheral nervous systems].
Sourty B; Rousseau A
Ann Pathol; 2020 Apr; 40(2):168-179. PubMed ID: 32192808
[TBL] [Abstract][Full Text] [Related]
31. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
32. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
33. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R
Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
[TBL] [Abstract][Full Text] [Related]
35. Hereditary SWI/SNF complex deficiency syndromes.
Agaimy A; Foulkes WD
Semin Diagn Pathol; 2018 May; 35(3):193-198. PubMed ID: 29397238
[TBL] [Abstract][Full Text] [Related]
36. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
[TBL] [Abstract][Full Text] [Related]
37. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
Schweizer Y; Meszaros Z; Jones DTW; Koelsche C; Boudalil M; Fiesel P; Schrimpf D; Piro RM; Brehmer S; von Deimling A; Kerl U; Seiz-Rosenhagen M; Capper D
J Neuropathol Exp Neurol; 2017 Aug; 76(8):655-664. PubMed ID: 28789476
[TBL] [Abstract][Full Text] [Related]
38. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
39. SWI/SNF-deficient undifferentiated malignancies: where to draw the line
Tessier-Cloutier B; Kleinman CL; Foulkes WD
J Pathol; 2022 Feb; 256(2):139-142. PubMed ID: 34767264
[TBL] [Abstract][Full Text] [Related]
40. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults.
Thomas C; Wefers A; Bens S; Nemes K; Agaimy A; Oyen F; Vogelgesang S; Rodriguez FJ; Brett FM; McLendon R; Bodi I; Burel-Vandenbos F; Keyvani K; Tippelt S; Poulsen FR; Lipp ES; Giannini C; Reifenberger G; Kuchelmeister K; Pietsch T; Kordes U; Siebert R; Frühwald MC; Johann PD; Sill M; Kool M; von Deimling A; Paulus W; Hasselblatt M
Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
